¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hereditary epithelial dystrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • hereditary tubulointerstitial nephritis
    À¯Àü´¢¼¼°ü»çÀÌÁúÄáÆÏ¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • hereditary hemorhagic telangiectasia(osler-weber-rendu disease,)
    À¯Àü¼ºÃâÇ÷¼º¸ð¼¼Ç÷°ü È®Àå
  • hereditary hemorrhagic angioma
    À¯Àü(¼º) ÃâÇ÷¼º Ç÷°üÁ¾.
  • hereditary hemorrhagic telangiectasia
    À¯Àü(¼º) ÃâÇ÷¼º ¸ð¼¼(Ç÷)°üÈ®Àå.
  • hereditary hemorrhagic telangiectasia
    À¯Àü¼º ÃâÇ÷ Ç÷°üÈ®Àå
  • hereditary hyposegmentation
    À¯Àü¼º ÀúºÐ ÀýÁõ.
  • hereditary labyrinthine deafness
    À¯Àü¼º ³»À̼º ³­Ã»(¡­Ò®ì¼àõÑñôé).
  • hereditary labyrinthine deafness
    À¯Àü¼º ³»À̼º ³­Ã»
  • hereditary leptocytosis
    À¯Àü¼º Ç¥ÀûÀûÇ÷±¸ Áõ°¡(Áõ).
  • hereditary lymphedema
    À¯Àü¼º¸²ÇÁºÎÁ¾
  • hereditary macular degeneration
    À¯Àü¼º Ȳ¹Ýº¯¼º(ë¶îîàõüÜÚèܨàõ).
  • hereditary methemoglobinemia
    À¯Àü¼º ¸ÞÆ®Çì¸ð±Û·ÎºóÇ÷Áõ.
  • hereditary methemoglobinemic cyanosis
    À¯Àü¼º ¸ÞÆ®Çì¸ð±Û·ÎºóÇ÷¼º û»öÁõ.
  • hereditary motor and sensory neuropathy
    À¯Àü¼º¿îµ¿ °¨°¢½Å°æº´Áõ
  • hereditary mutilating keratoma
    À¯Àü¼º Àý´Ü °¢È­Á¾
  • hereditary myotonia
    À¯Àü¼º ±Ù±äÀåÁõ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • squamous epithelial cell
    ÆíÆò»óÇǼ¼Æ÷
  • superficial epithelial cell
    Ç¥Ãþ»óÇǼ¼Æ÷, Ç¥¸é¼¼Æ÷(øúØüá¬øà).
  • superficial epithelial cell
    Ç¥¸é¼¼Æ÷
  • superficial epithelial cell
    Ç¥¸é»óÇǼ¼Æ÷
  • surface epithelial cell
    Ç¥¸é»óÇǼ¼Æ÷
  • transitional epithelial cell
    ÀÌÇà»óÇǼ¼Æ÷
  • visceral epithelial cell
    ³»Àå»óÇǼ¼Æ÷(Ò®íôß¾ù«á¬øà)
  • visceral epithelial cell,of glomerulus
    »ç±¸Ã¼ÀÇ ¡­
  • adrenogenital dystrophy
    ºÎ½Å¼º±â¹ßÀ°ÀÌ»ó(ÜùãìàõÐïÛ¡ëÀì¶ßÈ), ºÎ½Å¼º±âÀÌ¿µ¾çÁõ(¡­ì¶ç½å×ñø).
  • albipunctate retinal dystrophy
    ÈòÁ¡¸Á¸·ÀÌ¿µ¾ç(Áõ)
  • basement membrane dystrophy
    ±âÀú¸·ÀÌ¿µ¾ç(Áõ)
  • beckers muscular dystrophy
    º£Ä¿ ±ÙÀÌ¿µ¾çÁõ(¡­ÐÉì£ç½å×ñø)
  • butterfly corneal dystrophy
    ³ªºñ¸ð¾ç°¢¸·ÀÌ¿µ¾ç(Áõ), Á¢Çü°¢¸·ÀÌ¿µ¾ç(Áõ)
  • butterfly-shaped retinal dystrophy
    ³ªºñ¸ð¾ç¸Á¸·ÀÌ¿µ¾ç(Áõ), Á¢Çü¸Á¸·ÀÌ¿µ¾ç(Áõ)
  • central areolar choroidal dystrophy
    Á߽ɼº¿øÇü¸Æ¶ô¸·ÀÌ¿µ¾ç(Áõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
ET educational therapy; effective temperature; ejection time; embryo transfer; endothelin; endotoxin; e...
FEH focal epithelial hyperplasia
GEC galactose elimination capacity; glomerular epithelial cell
HEP hemolysis end point; hepatoerythropoietic porphyria; high egg passage [virus]; high-energy phosphate...
HFEC human foreskin epithelial cell
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
MD Myotonic Dystrophy
MyD Myotonic Dystrophy
MMD Myotonic muscular dystrophy
MyD Myotonic muscular dystrophy
NAD Neuroaxonal dystrophy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • epithelial opacity
    »óÇÇ È¥Å¹
  • epithelial reattachment
    »óÇÇ ÀçºÎÂø
  • epithelial remnant
    »óÇÇ ÀÜÁ¸¹°
  • epithelial rim
    »óÇÇ µÑ·¹
  • epithelial sac
    »óÇÇ ³¶
  • epithelial sheath
    »óÇÇ Áý, »óÇÇ ÃÊ
  • epithelial tag
    »óÇÇ ²¿¸®
  • epithelial tissue
    »óÇÇ Á¶Á÷
    ¼¼Æ÷ »çÀÌ ¹°ÁúÀÌ °ÅÀÇ ¾ø¾î ÀÎÁ¢ ¼¼Æ÷¿Í ¹ÐÂøµÇ¾î ±¸¼ºÇϰí ÀÖÀ¸¸ç, Àå±âÀÇ Ç¥¸éÀ» µ¤°Å³ª ³»°­ÀÇ Ç¥¸éÀ» µ¤À¸¸ç ÀϺδ »ùÀ» ±¸¼ºÇÑ´Ù.
  • focal epithelial
    ±¹¼Ò¼º »óÇÇ
  • Hertwig's epithelial sheath
    Ç츣ƮºñÈ÷ »óÇÇÃÊ
    ¹Ì¸ÍÃâ Ä¡¾Æ ÁÖÀ§ ¹× ¹ý¶û±â¿¡¼­ÀÇ µ¹Ãâ¿¡ ÀÇÇØ Çü¼ºµÇ´Â Ä¡¼Ò³¶ ³»ÀÇ »óÇÇ ¼¼Æ÷ÀÇ ¿ÜÇÇ.
  • paradental epithelial cyst
    Ä¡ÁÖ¼º »óÇdz¶
  • primary epithelial band
    ÀÏÂ÷ »óÇÇ ¶ì
  • removable epithelial coating
    °¡Ã¶¼º »óÇÇ ÇǸ·
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
ring-like corneal dystrophy Thread-like opacities of the anterior corneal stroma, with acute, painful onset followed by decreased vision; autosomal dominant inheritance.
(05 Mar 2000)
gutter dystrophy of cornea A marginal furrow usually inferiorly about 1 mm from the limbus; and sometimes bilateral.
Synonym: keratoleptynsis.
(05 Mar 2000)
colourectal neoplasms, hereditary nonpolyposis A syndrome characterised by autosomal dominant inheritance, a low mean age (41 years) for occurrence of colon cancer, and a marked increase in the proportion of tumours in the proximal colon.
(12 Dec 1998)
mucopolysaccharide keratin dystrophy A histologic finding seen in the surface epithelium of oral inflammatory fibrous hyperplasia, consisting of homogeneous eosinophilic pools of material in the superficial spinous layer.
(05 Mar 2000)
cone dystrophy A retinal abnormality in which colour perception is severely deficient and typical changes occur in electroretinogram.
See: achromatopsia.
Synonym: cone degeneration.
(05 Mar 2000)
muscular dystrophy A group of diseases characterised by progressive degeneration and/or loss of muscle fibres without nervous system involvement. All or nearly all of them have a hereditary origin but details of the type of genetic defect and of the prognosis for the disease vary from type to type. Duchenne muscular dystrophy (pseudohypertrophic muscular dystrophy) is the most common form. It is due to a sex-linked recessive allele and this is expressed as an absence of the protein dystrophin, the disease in boys shows extensive but insufficient muscle fibre reformation from satellite cells.
(18 Nov 1997)
corneal dystrophies, hereditary Bilateral hereditary disorders of the cornea, usually autosomal dominant, which may be present at birth but more frequently develop during adolescence and progress slowly throughout life. Central macular dystrophy is transmitted as an autosomal recessive defect.
(12 Dec 1998)
corneal dystrophy Central corneal opacification, usually bilateral, symmetrical, and often autosomal recessive, involving predominantly epithelial, stromal, or endothelial layers, often in a typical pattern.
(05 Mar 2000)
myotonic dystrophy <neurology> An inherited human neuromuscular disease classed as an autosomal dominant disease in which there is progressive muscle weakening and wasting.
A triplet repeat syndromes (like fragile X syndrome), this most common adult form of muscular dystrophy is caused by expansion of the unstable trinucleotide repeat CTG in the 3' untranslated region on chromosome 19q13 (cAMP-dependent muscle protein kinase gene).
Anticipation has been associated with further expansion of the repeat upon transmission to subsequent generations (the inheritance pattern is autosomal dominant), although contraction has been noted to occur as well. Especially severe neonatal cases have been born to affected mothers preferentially, suggesting a role for genomic imprinting as well.
The classic physical signs include atrophy of facial muscles, cataracts, and delayed muscle relaxation. Detection of the expanded trinucleotide repeat is accomplished by PCR or Southern blot and expansion appears to correlate with decreased transcription of the protein kinase gene.
Inheritance: autosomal dominant.
(29 Dec 1997)
craniocarpotarsal dystrophy Congenital association of skeletal defects (ulnar deviation of hands with camptodactyly, talipes equinovarus, and frontal bone defects) and characteristic facies (protrusion of lips as in whistling, sunken eyes with hypertelorism, and small nose); autosomal dominant inheritance.
Synonym: craniocarpotarsal dysplasia, Freeman-Sheldon syndrome, whistling face syndrome.
(05 Mar 2000)
progressive muscular dystrophy A form of progressive muscular atrophy in which the disease begins in the muscle and not in the spinal centres.
Synonym: Erb atrophy, idiopathic muscular atrophy.
(05 Mar 2000)
progressive tapetochoroidal dystrophy An x chromosome-linked abnormality characterised by atrophy of the choroid and degeneration of the retinal pigment epithelium causing night blindness.
(12 Dec 1998)
hereditary <genetics> Transferred via genes from parent to child.
(16 Dec 1997)
hereditary amyloidosis <neurology> A disorder in which various peripheral nerves are infiltrated with amyloid and their functions disturbed, an abnormal prealbumin is also formed and is present in the blood; characteristically, it begins during mid-life and is found largely in persons of Portuguese descent. Other rare clinical types occur.
Inheritance: autosomal dominant.
Synonym: familial amyloidosis, hereditary amyloidosis.
(05 Mar 2000)
hereditary angioedema A genetic form of angioedema. (angioedema is also referred to as quinke's disease.) persons with it are born lacking an inhibitor protein (called c1 esterase inhibitor) that normally prevents activation of a cascade of proteins leading to the swelling of angioedema. Patients can develop recurrent attacks of swollen tissues, pain in the abdomen, and swelling of the voice box (larynx) which can compromise breathing. The diagnosis is suspected with a history of recurrent angioedema. It is confirmed by finding abnormally low levels of c1 esterase inhibitor in the blood. Treatment options include antihistamines and male steroids (androgens) that can also prevent the recurrent attacks. Also called hereditary angioneurotic oedema.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á